Cancer Risk

BSD Medical Reports Impressive Results From Clinical Study On Pancreatic Cancer Presented At ESHO 2010 Meeting
BSD Medical Corporation (NASDAQ: BSDM) reported considerable formula from the clinical investigate upon the operate of hyperthermia, delivered regulating the BSD-2000 Hyperthermia System, to provide pancreatic cancer. Dr. S. Maluta, University Hospital of Verona, Italy, reported the formula of the randomized Phase II investigate of 74 patients with modernized pancreatic cancer: “Hyperthermia total with radiochemotherapy in …

Cancer Topics: 2010, Cancer, Clinical, ESHO, from, Impressive, impressive results, Medical, medical corporation, Meeting, Pancreatic, Pancreatic Cancer, Presented, Reports, results, Study, verona italy